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Human adult hemoglobin modified by both pyridoxal-5'-phosphate and glutaraldehyde in the 
oxy-form was studied by Mössbauer spectroscopy. Mössbauer spectra were measured at 87 and 
295 K (hemoglobin in lyophilized form) and at 87 K (hemoglobin in frozen solution). The values 
of the quadrupole splitting for modified oxyhemoglobin were found to be lower then those of 
oxyhemoglobin without modifications in lyophilized form and frozen solution, respectively. The 
Mössbauer spectra of modified oxyhemoglobin were also analyzed in terms of the heme iron 
inequivalence in a- and /3-subunits of the tetramer. Differences of the tendencies of temperature 
dependencies of quadrupole splitting for modified and non-modified oxyhemoglobin in lyophilized 
form were shown. 
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Introduction 
The chemically modified hemoglobin is a useful 
blood substitute [1,2]. Pyridoxal phosphate and glu-
taraldehyde are widely used reagents for hemoglobin 
modifications. Hemoglobin chemically modified by 
pyridoxal phosphate has lower oxygen affinity [3, 4] 
while further cross-linking by glutaraldehyde in-
creases the oxygen affinity of modified hemoglobin 
[5, 6]. It is known that pyridoxal phosphate binds to 
the N-terminal NH2 groups of both a - and /5-chains, 
however the change of the oxygen affinity is related 
with pyridoxylated /^-chains [3]. The reaction of glu-
taraldehyde with hemoglobin is not clear yet [7]. It 
is known that glutaraldehyde reacts with lysines by 
intramolecular cross-linking of hemoglobin and poly-
meric cross-linking of hemoglobin molecules. 
Mössbauer spectroscopy, as one of the sensitive 
techniques to study the heme iron electronic struc-
ture, was applied to investigate the glutaraldehyde 
effect on hemoglobin in [8, 9]. The authors observed 
a small increase of quadrupole splitting (AEQ) for 
cross-linked oxyhemoglobin (Hb02) in comparison 
with the native one that was interpreted as varia-
tions of the heme iron stereochemistry in modified 
oxyhemoglobin. It should be noted that some other 
studies of modified hemoglobins by Mössbauer spec-
troscopy revealed also small differences of Mössbauer 
parameters. For instance, a Mössbauer effect study 
of deoxy- and oxyhemoglobin modified with N-
ethylmaleimide or carboxypeptidase A, respectively, 
demonstrated an increase of AEQ in comparison with 
non-modified hemoglobin [10, 11]. Earlier we used 
Mössbauer spectroscopy to reveal some differences 
of AEQ for adult and fetal oxyhemoglobins [12 - 15], 
normal adult and patient's oxyhemoglobins [13, 15, 
16], as well as for oxyhemoglobin in solution and 
in lyophilized form [15, 17], These and some other 
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results demonstrated that small variations of the heme 
iron electronic structure and stereochemistry may be 
reflected by small variations of AEQ [18]. Therefore 
we applied Mössbauer spectroscopy for the analysis 
of the heme iron electronic structure and the stereo-
chemistry in oxyhemoglobin modified by pyridoxal 
phosphate and glutaraldehyde. 
Materials and Methods 
Hemoglobin Preparation 
Freshly outdated human adult red blood cells were 
obtained from the Blood Bank of the Hematologi-
cal Scientific Center, Moscow. The washed red blood 
cells were lysed by hypotonic hemolysis. The stro-
mal lipoproteins were removed by acid precipitation 
with 0.5 M ascorbic acid. The precipitate was imme-
diately separated by the tangential-flow filtration with 
a Pellicon crossflow filtration cell using 0.45 |J.m and 
0.22 (im Durapore cassettes. The hemoglobin solu-
tion was concentrated to 200 g/1 and then dialyzed in 
the filtration mode against 0.9% NaCl solution. The 
concentrated solution obtained was sterilized by pas-
sage through a sterile 0.22 fim Millipore filter. Details 
of the hemoglobin preparation were given in [19]. 
The hemoglobin modification was made in the de-
oxygenated form. Pyridoxal-5'-phosphate (PLP) (Re-
anal, Hungary) was added in a 4:1 molar ratio to 
deoxyhemoglobin in solution. Sodium borohydride 
was added to the hemoglobin solution to form a co-
valent bond with PLP. Then the hemoglobin solu-
tion was dissolved to 5 g% and glutaraldehyde (GA) 
(Serva, Germany) was added in a 10:1 molar ratio 
to the hemoglobin solution. The hemoglobin solu-
tion was dialyzed and concentrated to 8-10 g% of 
hemoglobin and then stabilized with glucose, sor-
bitol, etc. Details of the hemoglobin modification 
were given in [20]. The methemoglobin concentration 
in solution was measured with an IL 282 Co-oxymeter 
and found to be 5%. The distribution of the molec-
ular weight of modified hemoglobin was determined 
by gel-chromatography on Sepharose CL-6B (Phar-
macia, Sweden). The part of polymeric hemoglobin 
was ~30%, while 70% of modified hemoglobin had 
internal cross-linking. The average molecular weight 
of modified hemoglobin was 140 kDa. The oxygen 
dissociation curve was determined using a Hem-O-
Scan (Aminco, USA). The value of P50 for modi-
fied hemoglobin was 28 mm Hg at pH 7.4, PCo, = 
40 mm Hg, 37 °C. The biochemical and functional 
properties of modified hemoglobin were discussed in 
[21,22]. 
Modified hemoglobin was oxygenated (Hb(PLP + 
GA)02), lyophilized and stored at low temperature. 
Part of the lyophilized modified oxyhemoglobin was 
dissolved in 0.9% NaCl solution and frozen by liq-
uid nitrogen. Non-modified oxyhemoglobin (Hb02) 
concentrated in solution (~38 g%) was prepared by 
method [23] and stored at liquid nitrogen temperature. 
A part of this oxyhemoglobin was also lyophilized 
and stored at low temperature (see [17]). 
Mössbauer Spectroscopy 
Mössbauer spectra were measured with the con-
stant acceleration computerized precision spectrom-
eter which was a part of a multi-dimension para-
metric Mössbauer spectrometer SM-2201 [24], The 
noise of the velocity signal of the spectrometer was 
1.5 x l0~ 3 mm/s, the drift of the zero point velocity 
was ±2.6x 10~3 mm/s, the nonlinearity of the veloc-
ity signal was 0.01%, the harmonic distortion factor 
was 0.005% for the frequency band in the range of 
0 - 1120 Hz. The parabolic distortion of the spectra 
was not more than 0.1% from the statistical counts 
which were in the range from 1.5 xlO6 to 2.6xlO6 
counts per channel. These characteristics of the driv-
ing system permitted us to increase the sensitivity of 
the Mössbauer spectrometer and the quality of the 
measured spectra in comparison with our previous 
data [12, 13, 16, 17], A 2.5x 109 Bq 57Co(Cr) source 
was used at room temperature. 
The Mössbauer spectra of oxyhemoglobin sam-
ples in lyophilized form and in frozen solution were 
measured at 87 K using a liquid nitrogen cryostat. 
Additional Mössbauer spectra of lyophilized oxyhe-
moglobin samples were measured at room tempera-
ture. Sodium nitroprusside was used as standard ab-
sorber. Mössbauer spectra were computer fitted with 
a least squares procedure using a Lorentzian line 
shape. Mössbauer parameters (quadrupole splitting 
AEQ, isomer shift 6, line width P, subspectrum area 
S, absorption effect) and statistical criteria \ 2 w e r e 
determined. The values of the Mössbauer parameters 
of the 57Fe in the beryllium window of the scintillator 
detector Be(57Fe) were determined from independent 
measurements and fixed during the oxyhemoglobin 
spectra fitting. The values of the isomer shift are given 
relative to a-Fe at 295 K. 
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Fig. 1. Mössbauer spec-
tra of oxyhemoglobin 
samples: A: Hb02 in 
frozen solution (T = 
87 K); B: Hb(PLP + 
GA)02 in lyophilized 
form (T = 87 K); C: 
Hb(PLP + GA)02 in 
lyophilized form (T = 
295 K); D: Hb(PLP + 
GA)02 in frozen solu-
tion (T = 87 K). The 
solid lines are the re-
sult of spectra fitting us-
ing two quadrupole dou-
blets for oxyhemoglobin: 
1: a-subunits in tetramer; 
2: /3-subunits in tetramer; 
3: unknown Fe3+ com-
pound; 4: Be(57Fe). Ver-
tical bars indicate statisti-
cal errors of each spectral 
point. 
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Table 1. Mössbauer parameters of oxyhemoglobin samples 
(one doublet fit).a FS: frozen solution, L: lyophilized form. 
b Taken from [17].c Average data for the line width of the 
left and right absorption peaks. 
2.20 
Samplea T 
[K] 
r 
[mm/s] 
6 
[mm/s] 
A Eq 
[mm/s] 
H b O , (FS) 87 0 . 3 7 7 ± 0 . 0 2 8 0 . 2 6 8 ± 0 . 0 1 4 2 . 0 8 4 ± 0 . 0 1 4 1.78 
H b ( P L P + G A ) 0 2 (L) 87 0 . 3 9 1 ± 0 . 0 2 2 0 . 2 6 5 ± 0 . 0 1 1 2 . 0 4 5 ± 0 . 0 1 1 1.86 
H b ( P L P + G A ) 0 2 (L) 297 0 . 3 8 3 ± 0 . 0 2 2 0 . 1 8 7 ± 0 . 0 1 1 1 .651±0 .011 1.08 
H b ( P L P + G A ) 0 ; (FS) 87 0 . 4 2 5 ± 0 . 0 2 2 0 . 2 5 6 ± 0 . 0 1 1 1 . 9 9 8 ± 0 . 0 1 1 1.29 
H b 0 2 (L) 
H b 0 2 (L ) b 
87 0 . 3 9 8 c ± 0 . 0 2 2 0 . 2 7 6 ± 0 . 0 1 1 2 . 1 3 9 ± 0 . 0 1 1 1.10 
297 0 . 4 4 6 c ± 0 . 0 2 2 0 . 1 7 5 ± 0 . 0 1 1 1 . 8 3 6 ± 0 . 0 1 1 1.01 
Results and Discussion 
Mössbauer spectra of oxyhemoglobin samples 
are shown in Figure 1. Previously we showed that 
Mössbauer spectra of oxyhemoglobins measured at 
87 K had a non-Lorentzian line shape and may be 
fitted in two ways: using one or two quadrupole 
split doublets [12- 14, 17]. We assumed that one 
quadrupole split doublet fit omitted the non-equi-
valence of the heme iron electronic structure and 
stereochemistry in a - and /?-subunits of tetrameric 
oxyhemoglobin, while a fit with two quadrupole dou-
blets took into account the inequivalence of the heme 
iron electronic structure and stereochemistry in a - and 
ß-subunits of tetrameric oxyhemoglobin. Therefore, 
we fitted the Mössbauer spectra of oxyhemoglobins 
in these two ways and compare them with data for 
non-modified oxyhemoglobin and previous results for 
lyophilized oxyhemoglobin [17], It should be noted 
that all measured spectra of oxyhemoglobins con-
tained an additional component which was related 
with an unknown high spin Fe3+ compound with 
slightly varied Mössbauer parameters. Earlier we ob-
served an additional compound in lyophilized oxy-
hemoglobin at 87 K and related this compound to 
hemochromes [17]. However, we will refrain from 
considering the nature of this additional unknown 
compound and discuss the results related to oxyhe-
moglobin only. 
One Quadrupole Split Doublet Fit 
Mössbauer parameters resulting from one doublet 
fit are given in Table 1. The low temperature values of 
AEQ for modified oxyhemoglobin in both lyophilized 
form and frozen solution were found to be lower 
than that for normal one in frozen solution. Previ-
ously we found that the AEq value of lyophilized 
100 200 300 
Temperature , K 
Fig. 2. Different tendencies of the temperature dependence 
of A Eq for Hb(PLP+GA)02 (O) and for Hb02 (•) in 
lyophilized form. 
normal oxyhemoglobin was higher than that of nor-
mal oxyhemoglobin in frozen solution (the difference 
of the AEQ values at 87 K was 0.055 mm/s). We ob-
served the same result for modified oxyhemoglobin in 
lyophilized form and frozen solution (the difference 
of the AEQ values at 87 K was 0.047 mm/s). This 
fact indicates that lyophilization may affect modi-
fied and non-modified oxyhemoglobin in the same 
way. Lyophilization of oxyhemoglobin may induce 
a change of the heme iron stereochemistry that in-
creases the distortion of the heme symmetry, leading 
to an increase of the electric field gradient (EFG) on 
the 57Fe nuclei in oxyhemoglobin. A modification of 
hemoglobin with PLP and GA leads to another change 
of the protein molecule which in the oxygenated form 
contains the heme iron with a more symmetrical elec-
tric field and, therefore, with a lower value of the EFG 
on the 57Fe nuclei. 
A comparison of the AEQ values for modified and 
non-modified oxyhemoglobins in lyophilized form 
measured at 87 K and room temperature, demon-
strated differences of about 0.1 mm/s at 87 K and 
about 0.2 mm/s at 297 K. The different tendencies of 
the temperature dependence of AEQ for lyophilized 
forms of modified and non-modified oxyhemoglobins 
are shown in Figure 2. These data reflect the different 
electron term schemes for the heme iron in both pro-
teins related to variations of its stereochemistry. 
It should be noted that the differences of the \ 2 
values showed that the one quadrupole split dou-
blet fit was not satisfactory for Mössbauer spec-
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Table 2. Mössbauer parameters of oxyhemoglobin samples (two doublets fit).a FS: frozen solution, L: lyophilized form. 
b Taken from [17].c Fixed parameter. 
Samplea T [K] f , [mm/s] <5, [mm/s] A£Q1 [mm/s] f2 [mm/s] S2 [mm/s] AEQ , [ % ] 5 2[%] x 2 
51 49 1.15 
52 48 1.10 
48 52 1.17 
44 56 0.99 
52 48 1.16 
50 50 1.02 
H b O , (FS) 
H b ( P L P + G A ) 0 , ( L ) 
H b ( P L P + G A ) C ^ ( L ) 
Hb(PLP+GA)C>2 (FS) 
H b 0 2 ( L ) b 
H b 0 0 ( L ) b 
87 0.251 ± 0 . 0 2 8 0 . 2 6 7 ± 0 . 0 1 4 2 . 1 7 3 ± 0 . 0 1 4 0 . 4 6 7 ± 0 . 0 2 8 0 .264±0 .014 1 .834±0.014 
87 0 . 2 4 6 ± 0 . 0 2 2 0 . 2 6 4 ± 0 . 0 1 1 2 .142±0 .011 0 . 4 3 7 ± 0 . 0 2 2 0 .264±0 .011 1 .757±0.011 
297 0.280 c 0 . 1 8 2 ± 0 . 0 1 1 1 .814±0.011 0.270 c 0 .190±0 .011 1 .519±0.011 
87 0 . 2 5 3 ± 0 . 0 2 2 0 .256±0 .011 2 .137±0 .011 0 . 4 2 2 ± 0 . 0 1 1 0 .252±0 .011 1 .776±0.011 
87 0.303° 0.281 ± 0 . 0 1 1 2 . 1 9 2 ± 0 . 0 1 1 0 . 5 2 6 ± 0 . 0 2 2 0 .253±0 .011 1 .987±0.011 
297 0.420 c 0 . 1 7 0 ± 0 . 0 1 1 1 .959±0.011 0.398 c 0 .182±0 .011 1.721 ± 0 . 0 1 1 
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Fig. 3. Different tendencies of the temperature depen-
dencies of A£"qj (o-subunits) and AEQ2 (/?-subunits) for 
Hb(PLP+GA)02 and for HbO, in lyophilized form. O: o-
subunits in Hb02; • : a-subunits in Hb(PLP+GA)02; o: 
/3-subunits in HbÖ2; •: /3-subunits in Hb(PLP+GA)02. 
tra of oxyhemoglobin frozen solutions and modi-
fied oxyhemoglobin in lyophilized form measured at 
87 K due to the asymmetrical (non-Lorentzian) ab-
sorption line shape. Previously we related this fact 
to the necessity of accounting for the iron elec-
tronic structure inequivalence in a - and /3-subunits 
of tetrameric hemoglobin and, therefore, with the ne-
cessity to fit Mössbauer spectra of hemoglobin using 
two quadrupole doublets with approximately equal 
areas [12, 13, 14, 17], 
Two Quadrupole Split Doublets Fit 
Mössbauer parameters of oxyhemoglobin samples 
obtained from a two quadrupole doublets fit are given 
in Table 2. The values of \ 2 obtained for Mössbauer 
spectra with asymmetry of the absorption line shape 
were lower than those given in Table 1. In several 
cases, mainly for Mössbauer spectra with symmet-
rical (Lorentzian) absorption line shape, one or two 
line widths were fixed during the fitting procedure, 
like it was done earlier [12, 14, 17, 25], For each 
Mössbauer spectrum the first quadrupole doublet was 
related to the 57Fe in a-subunits while the second 
quadrupole doublet was related to the 57Fe in ß-
subunits of tetrameric oxyhemoglobin (details were 
given in [17, 18]). 
A compar ison of the AEqX and AEq2 values for 
various oxyhemoglobin samples measured at 87 K 
showed that larger differences of the quadrupole split-
ting were observed for the 57Fe in /3-subunits (0.05 
- 0 . 1 6 mm/s), while those for the 57Fe in a-sub-
units were 0.02 - 0.04 mm/s. The differences of the 
quadrupole splitting for modified and non-modified 
oxyhemoglobin in lyophilized form measured at room 
temperature were 0.15 mm/s and 0.20 mm/s for the 
57Fe in a - and /3-subunits, respectively. This fact in-
dicates that the temperature dependencies of A E q for 
a - and /?-subunits behave differently and the heme 
iron has a different electronic structure in a - and 
/3-subunits. The lyophilization process changes the 
heme iron stereochemistry in both subunits of non-
modified oxyhemoglobin in comparison with that in 
frozen solution. A comparison of the AEq { and AEq 2 
values for modified oxyhemoglobin in frozen solution 
and lyophilized form did not reveal any differences. 
It was interesting to compare the tendencies of the 
temperature dependencies of AEq for a- and /?-sub-
units in modified and non-modified oxyhemoglobin 
in lyophilized form (see Figure 3). The observed dif-
ferences indicate some variations of the changes of 
the heme iron electronic term scheme in a- and ß-
subunits, respectively, for modified and non-modified 
oxyhemoglobin. 
Conclusion 
A Mössbauer study of pyridoxylated hemoglobin 
cross-linked by glutaraldehyde in the oxy-form 
Unauthenticated
Download Date | 7/20/19 1:30 AM
198 M. I. Oshtrakh et al. • Quadrupole Splitting in Modified Oxyhemoglobin 
demonstrated that the heme iron electronic struc-
ture and stereochemistry is influenced by hemoglobin 
modification. Therefore, the oxygen affinity of mod-
ified hemoglobin may depend on both steric modifi-
cations of the protein and changes of the heme iron 
electronic structure and stereochemistry. 
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